Opportunity Information: Apply for RFA CA 24 005

Cancer Prevention, Detection, Diagnosis, and Treatment Technologies for Global Health (U01 Clinical Trial Optional) is a National Institutes of Health, National Cancer Institute funding opportunity (RFA-CA-24-005) that aims to move practical cancer technologies closer to real-world use in low- and middle-income countries (LMICs). The focus is on turning an existing or emerging assay, device, or treatment-enabling technology into a user-friendly, low-cost solution that can realistically function in LMIC clinical and community settings. Rather than funding early concept exploration, this announcement expects applicants to begin with a working prototype or assay platform (it does not have to be originally designed for cancer) and then adapt it to a clearly defined cancer prevention, detection, diagnosis, or treatment use case relevant to LMIC needs.

The award mechanism is a U01 cooperative agreement, which generally means NIH staff will have substantial scientific and programmatic involvement during the project, and the work is expected to be milestone-driven. Projects are expected to show more than incremental engineering: teams must demonstrate technical functionality and clinical performance for the proposed LMIC context, using objective performance milestones. The FOA emphasizes an iterative pathway where the technology is adapted, tested, improved, and validated in the settings where it is intended to be deployed, rather than being developed exclusively in high-resource environments and only later introduced abroad. Clinical trials are optional, so proposals may include clinical evaluation when appropriate, but they are not mandatory for every project.

A defining theme is implementation realism. Applicants are expected to treat affordability, cost-effectiveness, and usability at the point-of-need as core design requirements, not afterthoughts. That includes designing for constraints common in LMIC environments, such as limited infrastructure, variable power and connectivity, constrained supply chains, limited specialist availability, and the need for robust performance under real-world conditions. The intended output is a new generation of practical, scalable cancer technologies that can be used where the cancer burden is high and resources are limited.

Because success requires more than technical performance, the FOA requires multidisciplinary teams. Every application team must include expertise spanning (1) engineering, assay development, or treatment technology development, (2) oncology, (3) global health care delivery (people who understand how care is actually delivered in LMIC systems), and (4) business development. The business development requirement signals that applicants should plan for pathways to manufacturing, distribution, servicing, regulatory strategy where relevant, adoption, and sustainability. In other words, the program is looking for technologies with a credible route to deployment and long-term use, not just promising lab results.

This opportunity sits within the NCI Affordable Cancer Technologies (ACTs) Program, which broadly targets cancer technology innovation that is cost-conscious and appropriate for lower-resource settings. The activity categories listed include education and health, and the CFDA numbers associated with the program are 93.394 and 93.395. While the scientific content centers on technology development and validation, the program framing reinforces that the end goal is improved cancer outcomes through tools that can be integrated into real care pathways in LMICs.

Eligibility is broad and includes many types of U.S.-based and non-U.S. organizations. Eligible applicants include state, county, city, township, and special district governments; independent school districts; public and state-controlled institutions of higher education; private institutions of higher education; federally recognized Native American tribal governments; tribal organizations that are not federally recognized; public housing authorities and Indian housing authorities; nonprofits with or without 501(c)(3) status (other than institutions of higher education); for-profit organizations (other than small businesses); and small businesses. The FOA also explicitly calls out additional eligible applicant categories such as historically black colleges and universities (HBCUs), Hispanic-serving institutions, tribally controlled colleges and universities (TCCUs), Alaska Native and Native Hawaiian serving institutions, Asian American and Native American Pacific Islander serving institutions (AANAPISISs), faith-based or community-based organizations, eligible federal agencies, U.S. territories or possessions, regional organizations, and non-domestic entities (foreign organizations). This breadth aligns with the program goal of encouraging partnerships that combine technical innovation with on-the-ground LMIC experience and deployment capability.

Key administrative details from the posted source include an original closing date of 2023-10-13, an award ceiling listed at $475,000, and the funding instrument type as a cooperative agreement. Overall, the FOA is best read as a targeted push to translate a functioning prototype into a validated, field-ready cancer technology for LMIC use, with clear expectations around milestones, multidisciplinary collaboration, and design choices driven by cost, usability, and delivery realities.

  • The National Institutes of Health in the education, health sector is offering a public funding opportunity titled "Cancer Prevention, Detection, Diagnosis, and Treatment Technologies for Global Health (U01 Clinical Trial Optional)" and is now available to receive applicants.
  • Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.394, 93.395.
  • This funding opportunity was created on 2023-04-20.
  • Applicants must submit their applications by 2023-10-13. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
  • Each selected applicant is eligible to receive up to $475,000.00 in funding.
  • Eligible applicants include: State governments, County governments, City or township governments, Special district governments, Independent school districts, Public and State controlled institutions of higher education, Native American tribal governments (Federally recognized), Public housing authorities/Indian housing authorities, Native American tribal organizations (other than Federally recognized tribal governments), Nonprofits having a 501 (c) (3) status with the IRS, other than institutions of higher education, Nonprofits that do not have a 501 (c) (3) status with the IRS, other than institutions of higher education, Private institutions of higher education, For-profit organizations other than small businesses, Small businesses, Others.
Apply for RFA CA 24 005

[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:

Browse more opportunities from the same agency: National Institutes of Health

Browse more opportunities from the same category: Education, Health

Next opportunity: Native American Research Centers for Health (NARCH) (S06 Clinical Trial Optional)

Previous opportunity: Democracy Commission Small Grants Program

Applicant Portal:

Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.

Apply for RFA CA 24 005

 

Applicants also applied for:

Applicants who have applied for this opportunity (RFA CA 24 005) also looked into and applied for these:

Funding Opportunity
SBIR Phase IIB Bridge Awards to Accelerate the Development of Cancer-Relevant Technologies Toward Commercialization (R44 Clinical Trial Optional) Apply for RFA CA 23 034

Funding Number: RFA CA 23 034
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: Case Dependent
Small Business Transition Grant For Early Career Scientists (R42 Clinical Trial Not Allowed) Apply for RFA CA 23 035

Funding Number: RFA CA 23 035
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: Case Dependent
Integrating Health Disparities into Immuno-Oncology (HDIO) (P20 Clinical Trial Not Allowed) Apply for RFA CA 23 038

Funding Number: RFA CA 23 038
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: $250,000
Translating Socioenvironmental Influences on Neurocognitive Development and Addiction Risk (TranSINDA) (R34 Clinical Trial Not Allowed) Apply for RFA DA 24 019

Funding Number: RFA DA 24 019
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: $450,000
Patient Engagement Resource Centers to Inform SUD Treatment Services Research (R24 Clinical Trial Optional) Apply for RFA DA 24 016

Funding Number: RFA DA 24 016
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: $350,000
Advancing Psychedelics Research for Treating Addiction (R01 Clinical Trial Not Allowed) Apply for RFA DA 24 028

Funding Number: RFA DA 24 028
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: $350,000
Advancing Psychedelics Research for Treating Addiction (R61/R33 Clinical Trial Required) Apply for RFA DA 24 024

Funding Number: RFA DA 24 024
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: $700,000
Advancing Psychedelics Research for Treating Addiction (R61/R33 Basic Experimental Study with Humans Required) Apply for RFA DA 24 029

Funding Number: RFA DA 24 029
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: $700,000
Emergency Medicine Research Career Development Program in the Neurological Sciences (EMRCDP-NS) (K12 - No Independent Clinical Trial Allowed) Apply for PAR 23 151

Funding Number: PAR 23 151
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: Case Dependent
NLM Grants for Scholarly Works in Biomedicine and Health (G13 Clinical Trial Not Allowed) Apply for PAR 23 183

Funding Number: PAR 23 183
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: $75,000
Field-Deployable, Low-Cost Point-of-Need Approaches and Technologies to Lower the Barriers to Substance Use Disorders (SUD) Diagnosis and Treatment (R43/R44 Clinical Trial Optional) Apply for RFA DA 24 018

Funding Number: RFA DA 24 018
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: $295,924
Field-Deployable, Low-Cost Point-of-Need Approaches and Technologies to Lower the Barriers to Substance Use Disorders (SUD) Diagnosis and Treatment (R41/R42 Clinical Trial Optional) Apply for RFA DA 24 017

Funding Number: RFA DA 24 017
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: $295,924
Accelerating Behavioral and Social Science through Ontology Development and Use: Research Network Projects (U01 Clinical Trial Not Allowed) Apply for PAR 23 182

Funding Number: PAR 23 182
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: $500,000
Limited Competition: Cooperative Human Tissue Network (CHTN; UM1 Clinical Trial Not Allowed) Apply for RFA CA 23 024

Funding Number: RFA CA 23 024
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: $800,000
Investigator-Initiated Research in Genomics and Health Equity (R01 Clinical Trial Optional) Apply for RFA HG 23 017

Funding Number: RFA HG 23 017
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: $500,000
Leveraging Social Networks to Promote Widespread Individual Behavior Change (R01 Clinical Trial Optional) Apply for RFA AG 24 025

Funding Number: RFA AG 24 025
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: $500,000
Leveraging Social Networks to Promote Widespread Individual Behavior Change (R34 Clinical Trial Optional) Apply for RFA AG 24 026

Funding Number: RFA AG 24 026
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: $225,000
NIH Neuroscience Development for Advancing the Careers of a Diverse Research Workforce (R25 Clinical Trial Not Allowed) Apply for PAR 23 178

Funding Number: PAR 23 178
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: Case Dependent
Substance Use/Substance Use Disorder Dissertation Research Award (R36 Clinical Trials Not Allowed) Apply for PAR 23 194

Funding Number: PAR 23 194
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: Case Dependent
The Blood and Marrow Transplant Clinical Trials Network - Data Coordinating Center (U24 Clinical Trial Not Allowed) Apply for RFA HL 24 011

Funding Number: RFA HL 24 011
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: Case Dependent

 

Grant application guides and resources

It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!

Apply for Grants

 

Inside Our Applicants Portal

  • Grants Repository - Access current and historic funding opportunities with ease. Thousands of funding opportunities are published every week. We can help you sort through the database and find the eligible ones to apply for.
  • Applicant Video Guides - The grant application process can be challenging to follow. We can help you with intuitive video guides to speed up the process and eliminate errors in submissions.
  • Grant Proposal Wizard - We have developed a network of private funding organizations and investors across the United States. We can reach out and submit your proposal to these contacts to maximize your chances of getting the funding you need.
Access Applicants Portal

 

Premium leads for funding administrators, grant writers, and loan issuers

Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.

If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.

Learn More

 

 

Request more information:

Would you like to learn more about this funding opportunity, similar opportunities to "RFA CA 24 005", eligibility, application service, and/or application tips? Submit an inquiry below:

Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.

 

Ask a Question: